Phase II trial of taxol in patients with metastatic renal cell carcinoma

Avi Israel Einzig, Elizabeth Gorowski, Jill Sasloff, Peter H. Wiernik

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Based on results of previous Phase I studies, 18 patients with documented metastastic renal cell carcinoma received Taxol 250 mg/m2 as a 24-h infusion, repeated every 21 days in this Phase II study. All patients received premedication with dexamethasone, diphenhydramine, and cimetidine. There were no responses in the 18 patients treated.

Original languageEnglish (US)
Pages (from-to)133-136
Number of pages4
JournalCancer Investigation
Volume9
Issue number2
DOIs
StatePublished - Jan 1 1991

Fingerprint

Paclitaxel
Renal Cell Carcinoma
Diphenhydramine
Premedication
Cimetidine
Dexamethasone

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Phase II trial of taxol in patients with metastatic renal cell carcinoma. / Einzig, Avi Israel; Gorowski, Elizabeth; Sasloff, Jill; Wiernik, Peter H.

In: Cancer Investigation, Vol. 9, No. 2, 01.01.1991, p. 133-136.

Research output: Contribution to journalArticle

Einzig, Avi Israel ; Gorowski, Elizabeth ; Sasloff, Jill ; Wiernik, Peter H. / Phase II trial of taxol in patients with metastatic renal cell carcinoma. In: Cancer Investigation. 1991 ; Vol. 9, No. 2. pp. 133-136.
@article{abbc6fb5d545471aa3d7ef2721835d5f,
title = "Phase II trial of taxol in patients with metastatic renal cell carcinoma",
abstract = "Based on results of previous Phase I studies, 18 patients with documented metastastic renal cell carcinoma received Taxol 250 mg/m2 as a 24-h infusion, repeated every 21 days in this Phase II study. All patients received premedication with dexamethasone, diphenhydramine, and cimetidine. There were no responses in the 18 patients treated.",
author = "Einzig, {Avi Israel} and Elizabeth Gorowski and Jill Sasloff and Wiernik, {Peter H.}",
year = "1991",
month = "1",
day = "1",
doi = "10.3109/07357909109044223",
language = "English (US)",
volume = "9",
pages = "133--136",
journal = "Cancer Investigation",
issn = "0735-7907",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Phase II trial of taxol in patients with metastatic renal cell carcinoma

AU - Einzig, Avi Israel

AU - Gorowski, Elizabeth

AU - Sasloff, Jill

AU - Wiernik, Peter H.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - Based on results of previous Phase I studies, 18 patients with documented metastastic renal cell carcinoma received Taxol 250 mg/m2 as a 24-h infusion, repeated every 21 days in this Phase II study. All patients received premedication with dexamethasone, diphenhydramine, and cimetidine. There were no responses in the 18 patients treated.

AB - Based on results of previous Phase I studies, 18 patients with documented metastastic renal cell carcinoma received Taxol 250 mg/m2 as a 24-h infusion, repeated every 21 days in this Phase II study. All patients received premedication with dexamethasone, diphenhydramine, and cimetidine. There were no responses in the 18 patients treated.

UR - http://www.scopus.com/inward/record.url?scp=0025878922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025878922&partnerID=8YFLogxK

U2 - 10.3109/07357909109044223

DO - 10.3109/07357909109044223

M3 - Article

C2 - 1677827

AN - SCOPUS:0025878922

VL - 9

SP - 133

EP - 136

JO - Cancer Investigation

JF - Cancer Investigation

SN - 0735-7907

IS - 2

ER -